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Children and adolescents affected by prenatal exposure to alcohol who have brain damage that is 
manifested in functional impairments of neurocognition, self-regulation, and adaptive functioning 
may most appropriately be diagnosed with neurobehavioral disorder associated with prenatal 
exposure. This Special Article outlines clinical implications and guidelines for pediatric medical 
home clinicians to identify, diagnose, and refer children regarding neurobehavioral disorder 
associated with prenatal exposure. Emphasis is given to reported or observable behaviors that can 
be identified as part of care in pediatric medical homes, differential diagnosis, and potential 
comorbidities. In addition, brief guidance is provided on the management of affected children in 
the pediatric medical home. Finally, suggestions are given for obtaining prenatal history of in utero 
exposure to alcohol for the pediatric patient.
Neurobehavioral disorder associated with prenatal alcohol exposure (ND-PAE) is a newly 
proposed mental health diagnosis associated with the teratogenic effects of in utero exposure 
to alcohol. This behavioral and mental health diagnosis is under the umbrella of fetal alcohol 
spectrum disorders (FASDs), which also includes fetal alcohol syndrome (FAS), partial FAS 
(pFAS), and alcohol-related birth defects; additional information is available at the 
American Academy of Pediatrics (AAP) Web site (http://www.aap.org/fasd).1 ND-PAE was 
introduced into the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition 
(DSM-5) of the American Psychiatric Association in 2013 as a “Condition for Further 
Study,” as well as a specified condition under “Other Specified Neurodevelopmental 
Disorder” (International Classification of Diseases, Ninth Revision code 315.8, International 
Classification of Diseases, 10th Revision code F88).2 The intent of this new diagnostic 
designation is to better capture the behavioral and mental health effects of in utero exposure 
to alcohol of individuals with and without the physical dysmorphia associated with prenatal 
alcohol exposure, in contrast to the term alcohol-related neurodevelopmental disorder, which 
applies only to individuals with neurobehavioral effects in the absence of physical 
dysmorphia effects.3,4 This report outlines the clinical manifestations of ND-PAE that are 
most salient for the pediatric medical home, including identification of children in need of 
evaluation, diagnosis, comorbid or differential diagnosis, referral, and management. 
Although they do not represent AAP policy, specific suggestions are provided for 
assessment of maternal use of alcohol during pregnancy at routine pediatric visits.
The most recent national data from the Centers for Disease Control and Prevention (CDC) 
indicate that alcohol consumption during pregnancy is not a rare event, with 10.2% of 
pregnant women reporting that they consumed alcohol in the past 30 days and 3.1% 
reporting binge drinking in the past 30 days.5 Furthermore, approximately half of 
pregnancies are unplanned, and a woman might not know she is pregnant until the sixth 
week of gestation or beyond, a period when she might still be consuming alcohol and 
causing damage.6 Thus, many pregnancies are alcohol-exposed and represent a population 
of children at risk for FASDs, especially ND-PAE. Recent studies including active, expert 
clinical assessment of school-aged children report estimates that ~2% to 5% of children in 
the United States have an FASD.7–10 Review of medical records indicates that most of these 
children are not identified or diagnosed.11
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Criteria for ND-PAE are based on extensive brain imaging and animal model studies of 
adverse effects of prenatal alcohol exposure despite the absence of physical features (ie, 
dysmorphia and growth restriction).3,12–14 In fact, only ~25% of children affected by in 
utero exposure to alcohol exhibit physical features.15 In 2011, under the auspices of the 
Interagency Coordinating Committee on Fetal Alcohol Spectrum Disorders, the National 
Institute on Alcohol Abuse and Alcoholism and the CDC convened a panel of experts to 
evaluate the research on FASDs not associated with the typical physical features. 
(Information on these proceedings can be found at http://www.niaaa.nih.gov/about-niaaa/
our-work/ICCFASD/proceedings/2011.) In their consensus statement, 3 major areas of 
impairment were identified: neurocognition, self-regulation, and adaptive functioning. These 
areas of deficit, along with evidence of in utero exposure to alcohol, formed the basis of the 
ND-PAE diagnostic criteria.3,13
CLINICAL FEATURES OF ND-PAE
Diagnosis of ND-PAE is appropriate if a child presents with impairment in neurocognition, 
impaired self-regulation, 2 impairments of adaptive functioning, and a history of more than 
minimal exposure to alcohol in utero (Table 1), as long as the disorder is not better explained 
by other factors (eg, genetic or teratogenic syndrome). Although these broad domains 
overlap with other disorders of childhood, specific deficits within them are indicative of ND-
PAE. As with any developmental condition, impairments in these domains present 
differently as a child matures. To aid identification of patients with ND-PAE across 
development, age-specific traits in the framework for the continuous and comprehensive 
developmental screening included in The Bright Futures Guidelines, fourth edition, are 
presented in Fig 1A, Fig 1B, and Fig 1C.16
Impairment in Neurocognition
Criteria for neurocognitive impairment include evidence of 1 of the following: global 
impairment, executive dysfunction, deficits in learning, memory problems, or trouble with 
visual–spatial reasoning. These criteria may be assessed by standardized testing, clinical 
observation, or, more often, clinical history. To ensure the integrity of the diagnostic criteria 
for ND-PAE, findings based on clinical observation or history are best if based on specific 
examples of impairment and documented in the medical record.
For global deficits, comprehensive standardized testing results are the gold standard. This 
might require referral for testing or coordination with school psychologists. However, for 
diagnosis it is important to recognize that not all affected children perform in the range of 
intellectual disability. Clinical research has found that 86% of individuals with any of the 
FASDs have an IQ in the low average or borderline ranges.17 The important point is that the 
child under consideration is functioning below what would be expected relative to his or her 
peers.
Even if global delay or impairment is not present, specific deficits can indicate 
neurocognitive impairment consistent with ND-PAE. Impairment in executive function often 
presents as poor planning skills, inflexibility, or difficulty with behavior inhibition.18 
Impaired learning or specific learning disabilities often manifest in the areas of math, visual–
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spatial reasoning, or abstract academic material. Finally, memory problems might be seen as 
problems remembering recently learned materials or repeatedly making the same mistake.19 
These particular types of learning and memory problems often lead caregivers and educators 
to mistakenly assume the child is being defiant or willfully disobeying rather than having 
genuine difficulty, the “can’t vs won’t” error.2,20,21
Self-Regulation
Impaired self-regulation might include difficulty regulating mood or behavior, attention 
deficits, or poor impulse control. Early signs of mood and behavior regulation problems 
might include sleep problems or severe reactions to discomfort for infants and extended 
tantrums for toddlers.22–25 For older children, increased incidence of externalizing behaviors 
and severe reactions to stress are most common.3,26,27 However, increased levels of anxiety 
and depression have been documented.27 Attention problems are often associated with 
prenatal alcohol exposure. Children with ND-PAE can have particular difficulty shifting 
attention, resulting in behavior problems. Poor impulse control is an additional 
impairment.28,29 These difficulties in all areas of self-regulation are particularly challenging 
for the entire family of a child with ND-PAE. The sleep problems and mood lability with 
frequent behavior outbursts, typically caused by frustration with task shifting, are often the 
presenting complaints to a pediatrician.30–32
Adaptive Functioning
Adaptive functioning is the ability to acquire daily skills for personal and social sufficiency. 
Impairment in adaptive functioning can occur in communication, social communication and 
interaction, daily living skills, or motor skills for very young children. Adaptive functioning 
is an area of special concern of children with ND-PAE because these impairments are 
pervasive across domains and situations as children age.3 Therefore, meeting this criterion 
requires impairment across 2 domains of adaptive functioning. Although most language 
milestones (eg, babbling, first words, and syntax) are acquired on schedule,33 individuals 
with ND-PAE might exhibit communication problems such as difficulty in understanding 
figurative language (eg, understanding idioms, jokes, or sarcasm) and social communication 
conventions (eg, how to effectively enter a conversation).30,34 Socially, they can be overly 
friendly with strangers, be at high risk of bullying, have difficulty learning social rules 
through experience (eg, how to join a group on the playground), or be highly susceptible to 
manipulation by others.35 Because of attention and memory problems, a child with ND-PAE 
might initially learn daily skills such as hygiene or house rules, yet maintaining those skills 
and organizing daily activities present a challenge.36,37 Finally, motor skills can be impaired 
at the fine motor level (eg, poor writing skills) or gross motor level (eg, poor coordination or 
balance).7,38
In Utero Exposure to Alcohol
Unlike FAS, which can be diagnosed when information about history of prenatal alcohol 
exposure is unavailable, diagnosing other conditions along the continuum of FASDs, 
including ND-PAE, requires a confirmed history of in utero exposure. There are clear and 
strong research human and animal data documenting adverse neurodevelopmental outcomes 
from moderate to heavy levels of prenatal exposure to alcohol36 and adverse reproductive 
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(eg, prematurity) effects from even very low exposure levels.39 Linking adverse 
neurodevelopmental outcomes to in utero exposure at these lower levels remains a challenge 
but can be revealed with more sensitive testing.40 Despite clear evidence for the association 
between prenatal exposure to alcohol and the wide profile of strengths and weaknesses that 
might be observed across children with ND-PAE, the specificity of the profile is not yet 
known. Therefore, the criterion of more than minimal gestational exposure is required for 
the ND-PAE diagnosis. More than minimal exposure is defined as maternal consumption of 
≥13 drinks per month during pregnancy (ie, any 30-day period of pregnancy). The “More 
than minimal” criterion is not intended to denote a threshold for safe consumption of alcohol 
during pregnancy. It is simply an acknowledgment of ongoing controversy about low levels 
of exposure and an attempt make sure the diagnosis was not overused because the base rate 
of drinking any alcohol among women of childbearing years is relatively high.5
Suggestions for obtaining a prenatal history of alcohol exposure are presented in the 
Appendix.
The primary care pediatrician needs to be aware that there is no known level of alcohol use 
during pregnancy that has been established as safe. The US surgeon general still advises that 
women who are pregnant, or are considering pregnancy, should abstain from consuming 
alcohol.41 Primary care pediatricians will want to provide this important health message to 
their adolescent patients and mothers-to-be and obtain information on prenatal exposure to 
alcohol for all patients.
DIFFERENTIAL AND COMORBID DIAGNOSES
As would be expected, symptoms associated with the diagnostic criteria of ND-PAE may be 
observed in children with other disabilities. The diagnosis must be applied with care and 
based on all available information, especially prenatal exposure history. It is important to 
keep in mind that the specific constellation of impairments and unique manifestations of the 
criteria are most relevant for recognition and diagnosis rather that the general symptom 
domains. Specifying co-occurring disorders can provide the most complete picture of the 
child’s strengths and weaknesses to determine treatment or referral course.42–45 Differential 
diagnoses of ND-PAE can be particularly challenging because the disorder does not always 
present the same way in all children because of differences in timing and amount of prenatal 
alcohol exposure and difference in genetic predispositions or postnatal environment.33,46 
Table 2 presents key differences between ND-PAE and several neurobehavioral conditions. 
The severity of presentation and the constellation of characteristics vary greatly from child 
to child.3,33,42–45 In a sample of children with FASDs, comorbid mental health conditions 
included (in descending order) mental retardation (ie, intellectual disability), sleep 
abnormalities, reactive attachment disorder, anxiety, posttraumatic stress disorder, 
oppositional defiant disorder, language disorder, learning disability, depression, bipolar 
disorder, some features of autism, and specific phobias.45,47 Other conditions such as 
enuresis, encopresis, and eating disorders may be present depending on the age of the 
child.32
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FASDs
The diagnosis of ND-PAE encompasses the behavioral, developmental, and mental health 
aspects of FASDs. Other diagnoses along the spectrum, such as FAS or pFAS, focus on 
structural and neurophysiological central nervous system abnormalities (eg, microcephaly or 
neurologic soft signs). Physical features such as facial dysmorphia or growth restrictions 
(either prenatal or postnatal) are required for FAS and pFAS. Thus, for children with both 
physical findings and behavioral findings consistent with ND-PAE, it is appropriate that a 
comorbid diagnosis of FAS or pFAS also be used.3
Intellectual Disability
As mentioned, a majority of children with any of the FASDs score in the low range of 
normative intellectual functioning.15 The history of more than minimal in utero exposure to 
alcohol will be a major decision point between children with ND-PAE comorbid with 
intellectual disability and children with intellectual disability due to another etiology. 
However, deficits specific to ND-PAE are recognized. For example, even with repeated 
experience and an IQ within normal limits, the memory and learning impairments of a child 
with ND-PAE may mean that he or she has difficulty with previously learned skills, such as 
finding his or her locker at school on a routine basis despite repeated instructions and 
practice48,49 or forgetting how to tie his or her shoes, despite previous mastery, and having 
to relearn that skill entirely. This is different from regression of emerging skills seen in some 
children with autism.33
Finally, children with intellectual disability without prenatal alcohol exposure tend to have 
lowered functioning across all neurocognitive domains. In contrast, individuals with ND-
PAE tend to have specific difficulty with nonverbal aspects of cognition such as visual–
motor skills, learning and memory for recently learned skills, and executive functioning, 
resulting in behavioral problems.3,49 Cognitive impairment coupled with behavioral 
problems should prompt clinicians to consider a diagnosis of ND-PAE.
Attention Problems
Current research demonstrates differences in manifestations of attention-deficit/hyperactivity 
disorder (ADHD) and FASDs. Behaviorally, children with FASDs have higher rates of social 
behavioral problems resulting from difficulties in social cognition and emotional 
processing.50 They might also be more likely to have problems dealing with overstimulation 
than children with simple ADHD.51 In contrast, children with ADHD due to etiology not 
attributable to alcohol have difficulty with focus and sustained attention.52 Medication for 
symptoms of ADHD can result in unexpected outcomes in children with a history of 
prenatal alcohol exposure.53,54 Stimulant medications are often ineffective for children with 
prenatal alcohol exposure.27,33 Care should be given to investigate whether in utero exposure 
to alcohol contributes to attention problems for any child because treatment and 
management plans could differ.2
Early Trauma
Children who experience early trauma (including physical events, psychological events, and 
abuse or neglect) often display serious behavioral problems, receiving a mental health 
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diagnosis of conduct disorder, oppositional defiant disorder, anxiety, or depression. Because 
of overlap between these other behavioral disorders and ND-PAE, at a general level 
(especially for the self-regulation component) it is important for a clinician to consider these 
as both differential and comorbid diagnoses. Until additional data are available about the 
validity and reliability of all childhood behavior disorders, including ND-PAE, this will 
continue to be a tricky diagnostic issue. Furthermore, for some children a history of early 
trauma, abuse, neglect, or parental loss will be the only presenting problem because children 
with prenatal exposure to alcohol are at higher risk for these negative events. Therefore, it is 
particularly important to obtain prenatal exposure history in these situations.18,55 Such early 
trauma has been shown to drastically worsen the effects of prenatal alcohol exposure and 
must be taken into account.55
Other Conditions
Children with diagnoses of conduct disorder, oppositional defiant disorder, or even 
posttraumatic stress disorder (PTSD) are often aggressive without appropriate provocation, 
whereas children with ND-PAE might have behavioral outbursts caused by situational 
frustrations they experience when interacting with others or by their own 
neurodevelopmental limitations.35 Furthermore, children with other early trauma diagnoses 
might have inappropriate social interactions but tend to withdraw from others as self-
protection, whereas children with ND-PAE are more likely to be overly friendly, seeking out 
companionship and social acceptance, although often in an inappropriate manner.35,56
Foster Care and Adoption
A special issue regarding ND-PAE and early trauma is that among children in the child 
welfare system and children adopted internationally. Researchers have found 
disproportionately high rates of children with FASDs, including diagnoses without physical 
features such as ND-PAE, in these populations.57–60 Because these children also often 
experience early trauma, separation, and poor early caregiving, they are at elevated risk for a 
comorbid diagnosis of reactive attachment disorder or PTSD after abandonment.61–64 
Obtaining information about, and documenting, possible prenatal exposures for all who have 
a current or history of involvement with the child welfare system is prudent clinical practice. 
Such information can inform assessments and evaluation at older ages.
Finally, although prenatal alcohol exposure does occur in various contexts and varying 
levels, the presence of ongoing alcohol or substance abuse in the home confers additional 
risk. Families with substance abuse problems are more likely to suffer from multiple forms 
of trauma, antisocial behavior, financial instability, and poverty.18 These factors can lead to 
additional comorbid conditions in a child with ND-PAE.
REFERRAL AND MANAGEMENT
Although providing appropriate diagnoses (including comorbidities) can make a positive 
impact by giving families and clinicians a framework for understanding a child’s behavior, it 
is only a starting point. Ongoing care is the major role of the pediatric medical home.65 
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Although specific and targeted early interventions have been shown to be most effective, 
more general special education and support services also improve outcomes.15,17,55,66,67
Individuals with FASDs, including children without physical stigmata, can experience a host 
of physical conditions and secondary disabilities including mental health problems, 
disrupted school experiences, trouble with the law, incarceration or confinement, 
inappropriate sexual behavior, alcohol or drug problems, dependent living, and problems 
with employment.17 In 1 study, only 8% of people diagnosed with FAS or a related 
condition did not have problems with independent living or employment. Even if this finding 
encompasses some amount of ascertainment bias because it is a clinical sample, the number 
of individuals with FASDs who do not achieve independent living is striking and cause for 
concern.15 Early diagnosis and treatment of children with FASDs, including ND-PAE, can 
reduce the risk of additional disabilities and adverse lifelong consequences. This protective 
effect of early diagnosis has been demonstrated in a number of studies.15,24,35,68 In addition, 
referral to other specialist may be warranted (eg, genetics, neurology, cardiology, 
nephrology).
Medications
The evidence base for pharmacologic treatment in this population is limited,53,69,70 with no 
medications indicated specifically for ND-PAE. Studies on human and animal models are 
inconclusive at this time, and more data are needed for proper guidance. However, findings 
from small pilot studies suggest that ADHD stimulant medication can improve hyperactive 
symptoms but not attention and impulsivity.71,72 And another small study found that 
neuroleptics can be more beneficial than psychostimulants for improving social skills.56 A 
poor or adverse clinical response to stimulants (ie, ineffective clinical response or significant 
side effects) can occur, and clinicians should plan to adjust medications as necessary. Such 
medication failure also might be an indicator to consider a diagnosis under the umbrella of 
FASDs.
Behavioral, Mental Health, and Academic Referrals
By definition ND-PAE is a behavioral or mental health diagnosis, and therefore such patients 
will benefit from referral to specialties that can address these needs.3,73,74 In addition, 
academic problems are a natural sequela of these primary disabilities. An overview of 
interventions developed specifically for these children found that effective interventions 
include explicit teaching techniques, repetitive presentation, and caregiver instructions about 
specific strengths and weaknesses associated with prenatal alcohol exposure.73,75,76 As with 
many aspects of ND-PAE, additional systematic research is needed to develop new 
intervention strategies and to get a clearer picture of the long-term effectiveness of available 
programs.24,73,74,77,78 However, a sample of currently available evidence-based and 
evidence-informed interventions are described in the online Supplemental Information.
It is important to remember that all aspects of the ND-PAE diagnosis (ie, neurocognition, 
self-regulation, and adaptive behavior) are developmental processes, and the type of 
specialty needed might change across development. For younger children, allied health 
referrals, such as physical or occupational therapies, might be most appropriate. Early 
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intervention might focus on general developmental skills for the infant or preschooler. 
Occupational therapy is often recommended for fine motor impairments, sensory integration 
problems, and emerging self-regulation problems.79 For older school-age children, several 
evidence-based interventions targeting specific skills and adapted for children with FASDs 
are available and can be recommended to school-age children. Several of these interventions 
are described in the online Supplemental Information.73 More information on such 
interventions is available at the National Organization on Fetal Alcohol Syndrome 
(www.NOFAS.org).
Older children with ND-PAE might need more traditional mental health services and can 
begin to benefit from modified insight-based therapies.27,80 Referral to a psychiatrist or 
psychologist can be appropriate. Referral for substance abuse evaluation or treatment also 
might be warranted.15,27 For the medical home provider, however, it is most effective to 
provide background information on the strengths and weaknesses of a child with ND-PAE in 
addition to child specific symptoms when making such a referral.
Of special note for this population is that many affected children and adolescents do not 
qualify for special education under standard criteria, yet they still need services.17,81 This 
gap must be addressed at the individual patient or student level. Psychoeducational testing 
(by school personnel or private psychologists) might be required for diagnostic confirmation 
and treatment planning. Creative solutions and closely engaging with the family, school, and 
community by the pediatric medical home can facilitate meaningful results (see the AAP 
FASD Toolkit at www.aap.org/fasd).82,83
Family Support
Parental education about ND-PAE, and even about FASDs in general, is particularly 
effective.84 For parents there might be fears about stigma or the legal implications of the 
child’s diagnosis. It is important that clinicians ask the difficult questions to screen for 
prenatal alcohol exposure when they suspect a child might have been prenatally exposed to 
alcohol.
Caregivers appreciate information about how the behavioral difficulties they experienced 
with their child were directly related to their child’s exposure to alcohol in utero.17,73,84 
Instruction on the use of explicit explanations that avoid idioms or other figurative language, 
the value of routines, and the need to relearn some skills and obtain repeated instruction is a 
practical technique. Furthermore, such instruction provides reassurance and support.64,73 It 
often helps to explain to parents that structural brain abnormalities and the resulting 
neurobehavioral manifestations their child has (eg, problems with poor problem solving and 
executive dysfunction) might make him or her less responsive to pharmacotherapy than other 
children with a developmental disability. The pediatric medical home is an ideal setting to 
provide such education and reassurance that the child’s primary care pediatrician will be 
available to work with the family to address problems as they arise.65 It is especially helpful 
for the clinician to explain that the vulnerabilities of a child with ND-PAE might not be 
readily recognizable by others. For example, the child’s good structural language skills and 
friendly nature can give a false impression of competence, and forgetting previously learned 
material might give a false impression of a defiant or oppositional disorder.74 Additionally, 
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the medical home provider caring for the child with ND-PAE can help explain how the 
needs of the child change across development and provide anticipatory care.
SUMMARY AND PEDIATRIC MEDICAL HOME PRACTICE SUGGESTIONS
The value of the medical home starts at the identification and diagnostic stage and continues 
through treatment planning and ongoing care. Although barriers to diagnosis and treatment 
remain,85 the AAP endorses the identification, diagnosis, referral, and management of all 
children and adolescents with FASDs, including ND-PAE. The brain damage that is caused 
by prenatal alcohol exposure is permanent and irreversible, resulting in impaired 
neurocognitive functioning regardless of IQ; however, interventions can improve function.
Although additional taxometric research on ND-PAE is needed, an extensive scientific 
literature already provides support for its constellation of symptoms and criteria. Several 
efforts are under way to obtain appropriate taxometric data, with results forthcoming (J. 
Kable, PhD, personal communication, 2015); our understanding may require modification 
once tested in a sizable cohort of children with developmental disabilities. Children and 
adolescents with ND-PAE can reach their full potential with proper identification, diagnosis, 
and treatment if clinicians and families work as a team, especially toward early 
identification, treatment, and family support.24,73 Diagnosis and care of the patient with ND-
PAE provides the child, family, and pediatric clinician with a lens through which to help that 
child reach his or her developmental potential. Specific points to consider are presented in 
Table 3.
Clinical and research evidence clearly indicates that children affected by ND-PAE and their 
families face substantial challenges. Although these recommendations do not represent AAP 
policy, early recognition in the medical home can capitalize on neural plasticity, early 
intervention, and ongoing support systems to maximize the developmental potential of these 
children. Thus the pediatric medical home plays a central role in maximizing the 
developmental outcomes of children with ND-PAE.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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FAS fetal alcohol syndrome
FASDs fetal alcohol spectrum disorders
ND-PAE neurobehavioral disorder associated with prenatal alcohol exposure
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APPENDIX: SUGGESTED SCREENING FOR PRENATAL EXPOSURE TO 
ALCOHOL
Maternal self-report remains the major approach for identifying alcohol consumption during 
pregnancy, even though women might be reluctant to reveal prenatal alcohol use.86 More 
accurate reports about alcohol use are elicited when screening is conducted in a 
nonjudgmental and nonconfrontational manner, respecting confidentiality.87,88 Use of 
alcohol by a mother during pregnancy should be assessed, avoiding questions that require 
“yes/no” answers (eg, “Do you drink alcohol?”). Because of the stigma associated with 
alcohol use during pregnancy, asking patients about prepregnancy drinking can improve 
accuracy of the screening. Questions about alcohol use can be imbedded in a general 
conversation about health behaviors during pregnancy (eg, smoking, diet, current 
medications). Furthermore, single binge drinking questions have been shown to be effective 
at identifying women at risk for alcohol use during pregnancy and are consistent with 
current CDC and National Institute on Alcohol Abuse and Alcoholism 
recommendations.89–91
Based on international work that involved minimal questioning and clinical experience, the 
ND-PAE workgroup suggests beginning screening with an introductory statement, such as “I 
ask all patients standard health questions to understand factors that may affect health of their 
child and their health.”89,92 To approach the topic of alcohol and quickly determine whether 
prenatal exposure occurred, the following sets of questions are suggested in the newest 
edition of Bright Futures16:
• “How often do you drink beer, wine or liquor in your household?” (Continue for 
any response other than “never”)
• “In the 3 months before you knew you were pregnant, how many times did you 
have 4 or more drinks in a day?”
• “During the pregnancy, how many times did you have 4 or more drinks in a 
day?”
If positive responses are given to any of the above questions, the clinician can follow up to 
determine frequency and extent of consumption by asking,
• “During the pregnancy, on average, how many days per week did you have a 
drink?”
• “During the pregnancy, on a typical day when you had an alcoholic beverage, 
how many drinks did you have?”
Any affirmative answer indicates maternal at-risk drinking; a brief intervention or referral is 
indicated. The Bright Futures Guidelines (4th ed) suggests that these questions be asked at 
the prenatal visit, at an initial postnatal well visit, for all new patients, based on clinical 
suspicion, and if a caregiver describes cognitive or behavioral concerns consistent with ND-
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PAE criteria.16 Documentation of findings is very important because not all criteria for a 
ND-PAE diagnosis might present in a single visit or might have emerged at the time of 
screening. For example, executive function deficits often do not become apparent until 
school age, but documentation of prenatal exposure to alcohol would put those deficits in the 
proper context.
One concern expressed by some clinicians is that obtaining exposure information will trigger 
scrutiny by child welfare agencies. The Child Abuse Prevention and Treatment Act does not 
require clinicians to report to Child Protective Services if a child has been prenatally 
exposed to alcohol. Referral to Child Protective Services is required if the child has been 
diagnosed with an FASD in the period between birth and 3 years. The intent of this referral 
is to develop safe care and possible treatment plans if needed, not to initiate punitive 
actions.93, 94
Although discussing prenatal alcohol exposure with patients might be a challenge, and some 
providers express discomfort about discussing alcohol use with their patients, it is an 
important component of both prenatal and postnatal care and is necessary for diagnosing 
FASDs.95
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FIGURE 1. 
FIGURE 1A. ND-PAE Age-Dependent Symptom Diagnosis Guidelines: Neurocognitive 
Domain.
FIGURE 1B. ND-PAE Age-Dependent Symptom Diagnosis Guidelines: Self-Regulation 
Domain.
FIGURE 1C. ND-PAE Age-Dependent Symptom Diagnosis Guidelines: Adaptive 
Domains.
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TABLE 1
DSM-5 Proposed Criteria for Neurobehavioral Disorder Associated With Prenatal Alcohol Exposure
A. More than minimal exposure to alcohol during gestation, including prior to pregnancy recognition. Confirmation of gestational 
exposure to alcohol may be obtained from maternal self-report of alcohol use in pregnancy, medical or other records, or clinical 
observation.
B. Impaired neurocognitive functioning as manifested by one or more of the following:
1. Impairment in global intellectual performance (i.e., IQ of 70 or below, or a standard score of 70 or below on a 
comprehensive developmental assessment).
2. Impairment in executive functioning (e.g., poor planning and organization; inflexibility: difficulty with behavioral 
inhibition).
3. Impairment in learning (e.g., lower academic achievement than expected for intellectual level; specific learning 
disability).
4. Memory impairment (e.g., problems remembering information learned recently; repeatedly making the same 
mistakes; difficulty remembering lengthy verbal instructions).
5. Impairment in visual–spatial reasoning (e.g., disorganized or poorly planned drawings or constructions; problems 
differentiating left from right).
C. Impaired self-regulation as manifested by one or more of the following:
1. Impairment in mood or behavioral regulation (e.g., mood lability; negative affect or irritability; frequent behavioral 
outbursts).
2. Attention deficit (e.g., difficulty shifting attention; difficulty sustaining mental effort).
3. Impairment in impulse control (e.g., difficulty waiting turn; difficulty complying with rules).
D. Impairment in adaptive functioning as manifested by two or more of the following, one of which must be (1) or (2):
1. Communication deficit (e.g., delayed acquisition of language; difficulty understanding spoken language).
2. Impairment in social communication and interaction (e.g., overly friendly with strangers; difficulty reading social 
cues; difficulty understanding social consequences).
3. Impairment in daily living skills (e.g., delayed toileting, feeding, or bathing; difficulty managing daily schedule).
4. Impairment in motor skills (e.g., poor fine motor development; delayed attainment of gross motor milestones or 
ongoing deficits in gross motor function; deficits in coordination and balance).
E. Onset of the disorder (symptoms in Criteria B, C, and D) occurs in childhood.
F. The disturbance causes clinically significant distress or impairment in social, academic, occupational, or other important areas of 
functioning.
G. The disorder is not better explained by the direct physiologic effects associated with postnatal use of a substance (e.g., a 
medication, alcohol or other drugs), a general medical condition (e.g., traumatic brain injury, delirium, dementia), another known 
teratogen (e.g., fetal hydantoin syndrome), a genetic condition (e.g., Williams syndrome, Down syndrome, Cornelia de Lange 
syndrome), or environmental neglect.
Reprinted with permission of the American Psychiatric Association.
Pediatrics. Author manuscript; available in PMC 2017 October 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Hagan et al. Page 21
TA
B
LE
 2
D
iff
er
en
tia
l D
ia
gn
os
is 
fo
r N
D
-P
A
E
N
eu
ro
co
gn
iti
v
e
Be
ha
v
io
ra
l R
eg
ul
at
io
n
A
da
pt
iv
e 
Fu
nc
tio
ni
ng
K
ey
 D
iff
er
en
tia
l F
ro
m
 N
D
-P
A
E
N
D
-P
A
E 
(fo
rm
erl
y 
re
fe
rre
d 
to
 a
s a
lc
oh
ol
-
re
la
te
d 
n
eu
ro
de
v
el
op
m
en
ta
l 
di
so
rd
er
In
te
lle
ct
ua
l s
ki
lls
 m
ay
 b
e 
in
 
th
e 
in
te
lle
ct
ua
lly
 d
ef
ic
ie
nt
 
ra
n
ge
 fo
r s
om
e 
bu
t n
ot
 m
os
t. 
D
ef
ic
its
 in
 ex
ec
u
tiv
e 
fu
nc
tio
ni
ng
 sk
ill
s, 
le
ar
ni
ng
, 
m
em
o
ry
,
 
an
d 
vi
su
al
 sp
at
ia
l 
re
as
o
n
in
g 
ar
e 
co
m
m
on
.
Se
lf-
re
gu
la
tio
n 
im
pa
irm
en
ts 
m
ay
 ta
ke
 th
e 
fo
rm
 o
f p
oo
r m
oo
d 
or
 b
eh
av
io
ra
l 
re
gu
la
tio
n 
sk
ill
s, 
at
te
nt
io
n 
de
fic
its
, a
nd
 
po
or
 im
pu
lse
 c
on
tro
l. 
Th
ey
 a
re
 b
es
t 
ch
ar
ac
te
riz
ed
 b
y 
ar
ou
sa
l d
ys
fu
nc
tio
n 
in
v
o
lv
in
g 
slo
w
er
 g
at
in
g 
of
 in
co
m
in
g 
st
im
ul
at
io
n 
an
d 
re
du
ce
d 
ca
pa
ci
ty
 to
 
in
hi
bi
t a
tte
nd
in
g 
to
 d
ist
ra
ct
in
g 
sti
m
ul
i. 
Th
ey
 re
sp
on
d 
to
 si
m
pl
ifi
ca
tio
n 
of
 se
ns
or
y 
in
pu
t (
few
er
 d
ist
ra
ct
er
s a
nd
 sl
ow
er
 
pr
es
en
ta
tio
n).
A
da
pt
iv
e 
fu
nc
tio
ni
ng
 sk
ill
s o
fte
n 
fa
ll 
be
lo
w
 th
at
 o
f t
he
ir 
ov
er
al
l I
Qs
, a
nd
 of
ten
 
th
er
e 
ar
e 
de
cl
in
es
 in
 th
ei
r s
ki
lls
 a
s t
he
y 
gr
ow
 o
ld
er
 re
la
tiv
e 
to
 th
ei
r p
ee
rs
. T
hi
s 
de
cl
in
e 
m
ay
 re
su
lt 
in
 th
e 
sta
nd
ar
d 
sc
or
es
 
be
in
g 
lo
w
er
 a
s 
th
ey
 a
ge
. T
he
y 
of
te
n 
ha
v
e 
im
pa
irm
en
ts 
in
 th
e 
pr
ag
m
at
ic
 
co
m
m
u
n
ic
at
io
n 
sk
ill
s, 
ar
e 
so
ci
al
ly
 
di
sin
hi
bi
te
d,
 a
nd
 h
av
e 
po
or
 m
ot
or
 sk
ill
s 
o
r 
co
o
rd
in
at
io
n,
 w
ith
 th
e 
la
tte
r b
ei
ng
 a
 
gr
ea
te
r d
ef
ic
it 
in
 y
ou
ng
 ra
th
er
 th
an
 o
ld
er
 
ch
ild
re
n.
N
ot
 a
pp
lic
ab
le
.
G
lo
ba
l d
ev
el
op
m
en
ta
l 
de
la
y 
or
 in
te
lle
ct
ua
l 
di
sa
bi
lit
y
Ch
ild
re
n 
w
ith
 g
lo
ba
l 
de
v
el
op
m
en
ta
l d
el
ay
 b
y 
de
fin
iti
on
 h
av
e 
im
pa
irm
en
ts 
in
 m
ul
tip
le
 d
om
ai
ns
 o
f 
fu
nc
tio
ni
ng
 (e
g,
 c
og
ni
tiv
e 
an
d 
m
ot
or
 fu
nc
tio
ni
ng
).
In
te
lle
ct
ua
l s
ki
lls
 a
re
 in
 th
e 
in
te
lle
ct
ua
lly
 d
ef
ic
ie
nt
 ra
ng
e 
by
 d
ef
in
iti
on
. T
hi
s o
fte
n 
in
v
o
lv
es
 IQ
 sc
ore
 <7
0 o
n 
m
o
st
 s
ta
nd
ar
di
ze
d 
te
sts
. 
O
th
er
 c
og
ni
tiv
e 
sk
ill
s g
en
er
al
 
co
n
sis
te
nt
 w
ith
 o
v
er
al
l I
Q.
B
eh
av
io
ra
l r
eg
ul
at
io
n 
sk
ill
s a
re
 v
ar
ia
bl
e,
 
de
pe
nd
in
g 
on
 th
e 
na
tu
re
 o
f t
he
 d
iso
rd
er
 
ca
u
sin
g 
th
e 
de
v
el
op
m
en
ta
l d
el
ay
s o
r 
in
te
lle
ct
ua
l d
isa
bi
lit
y 
an
d 
th
e 
ex
te
nt
 o
f t
he
 
br
ai
n 
da
m
ag
e.
A
da
pt
iv
e 
fu
nc
tio
ni
ng
 sk
ill
s a
re
 a
lso
 in
 th
e 
lo
w
 o
r 
de
fic
ie
nt
 ra
ng
e 
an
d 
ar
e 
ge
ne
ra
lly
 
st
ab
le
 o
v
er
 th
e 
lif
et
im
e 
re
la
tiv
e 
to
 p
ee
rs
 
an
d 
co
ns
ist
en
t w
ith
 th
ei
r l
ev
el
s o
f 
in
te
lle
ct
ua
l f
un
ct
io
ni
ng
.
•
O
ve
ra
ll 
de
v
el
op
m
en
t o
r I
Q 
is 
oft
en
 
n
o
t d
el
ay
ed
 o
r i
nt
el
le
ct
ua
lly
 im
pa
ire
d 
in
 N
D
-P
A
E.
 E
ar
ly
 d
ev
el
op
m
en
ta
l 
pr
ob
le
m
s i
n 
N
D
-P
A
E 
ar
e 
of
te
n 
de
te
ct
ed
 in
 m
ot
or
 fu
nc
tio
ni
ng
 o
r 
qu
al
ity
 o
f m
ot
or
 fu
nc
tio
ni
ng
. T
he
 
co
gn
iti
v
e 
de
fic
its
 m
ay
 n
ot
 b
e 
de
te
ct
ab
le
 in
 th
e 
fir
st 
ye
ar
 o
f l
ife
 o
n 
m
ea
su
re
s 
o
f e
ar
ly
 c
hi
ld
ho
od
 
de
v
el
op
m
en
t.
•
Ch
ild
re
n 
w
ith
 N
D
-P
A
E 
ha
v
e 
be
ha
v
io
ra
l r
eg
ul
at
io
n 
de
fic
its
, a
nd
 
th
os
e 
w
ith
 in
te
lle
ct
ua
l d
isa
bi
lit
y 
m
ay
 
n
o
t.
•
Ch
ild
re
n 
w
ith
 N
D
-P
A
E 
ha
v
e 
ad
ap
tiv
e 
sk
ill
s b
el
ow
 IQ
 or
 de
cli
nin
g w
ith
 ag
e.
A
D
H
D
O
ve
ra
ll 
IQ
 is
 ty
pic
all
y w
ith
in 
n
o
rm
al
 li
m
its
, b
u
t o
fte
n 
in
di
v
id
ua
ls 
w
ith
 A
D
H
D
 h
av
e 
le
ar
ni
ng
 d
iff
ic
ul
tie
s a
nd
 m
ay
 
be
 a
ca
de
m
ic
 u
nd
er
ac
hi
ev
er
s.
A
D
H
D
 is
 c
ha
ra
ct
er
iz
ed
 b
y 
pr
ob
le
m
s w
ith
 
su
st
ai
ni
ng
 a
tte
nt
io
n 
an
d 
be
in
g 
im
pu
lsi
v
e 
o
r 
hy
pe
ra
ct
iv
e.
 T
he
 d
iso
rd
er
 m
ay
 b
e 
se
en
 
as
 b
ei
ng
 c
hr
on
ic
al
ly
 u
nd
er
ar
ou
se
d,
 a
nd
 
in
di
v
id
ua
ls 
re
sp
on
d 
to
 st
im
ul
an
t 
m
ed
ic
at
io
ns
 a
nd
 in
cr
ea
se
s i
n 
ar
ou
sa
l 
(ex
er
ci
se
 a
nd
 m
ov
em
en
t o
r i
nc
re
as
in
g 
ar
o
u
sa
l l
ev
el
 o
f l
ea
rn
in
g 
m
at
er
ia
l).
A
da
pt
iv
e 
sk
ill
 d
ef
ic
its
 a
re
 o
fte
n 
pr
es
en
t i
n 
u
n
tr
ea
te
d 
in
di
v
id
ua
ls 
w
ith
 A
D
H
D
 b
u
t 
w
ith
 a
pp
ro
pr
ia
te
 su
pp
or
ts 
an
d 
m
ed
ic
at
io
n 
m
ay
 b
e 
ag
e 
ap
pr
op
ria
te
.
•
Th
e 
ex
te
nt
 o
f n
eu
ro
co
gn
iti
v
e 
im
pa
irm
en
t i
s o
fte
n 
gr
ea
te
r i
n 
ch
ild
re
n 
w
ith
 N
D
-P
A
E 
th
an
 th
os
e 
w
ith
 A
D
H
D
.
•
Ch
ild
re
n 
w
ith
 N
D
-P
A
E 
al
so
 
de
m
on
str
at
e 
de
cl
in
es
 in
 a
da
pt
iv
e 
sk
ill
s w
ith
 a
ge
.
•
Ch
ild
re
n 
w
ith
 N
D
-P
A
E 
de
te
rio
ra
te
 
u
n
de
r c
on
di
tio
ns
 o
f h
ig
h 
ar
ou
sa
l, 
bu
t 
th
os
e 
w
ith
 A
D
H
D
 o
fte
n 
im
pr
ov
e.
A
SD
In
te
lle
ct
ua
l s
ki
lls
 v
ar
y,
 
w
ith
 
so
m
e 
be
in
g 
in
 th
e 
se
v
er
el
y 
in
te
lle
ct
ua
lly
 d
ef
ic
ie
nt
 ra
ng
e 
an
d 
ot
he
rs
 fu
nc
tio
ni
ng
 w
ith
in
 
n
o
rm
al
 li
m
its
 o
r g
ift
ed
.
Ea
sil
y 
ov
er
ar
o
u
se
d 
an
d 
be
ne
fit
 fr
om
 
re
du
ci
ng
 se
ns
or
y 
in
pu
t d
ur
in
g 
in
str
uc
tio
n.
A
da
pt
iv
e 
sk
ill
s a
re
 o
fte
n 
de
fic
ie
nt
, b
u
t 
ty
pi
ca
lly
 th
ey
 h
av
e 
re
la
tiv
e 
de
fic
its
 in
 th
e 
so
ci
al
 a
nd
 c
om
m
un
ic
at
io
n 
sk
ill
s a
s 
co
m
pa
re
d 
w
ith
 th
ei
r i
nd
ep
en
de
nt
 li
v
in
g 
sk
ill
s.
•
Ch
ild
re
n 
w
ith
 A
SD
 a
re
 c
ha
ra
ct
er
iz
ed
 
by
 b
ei
ng
 so
ci
al
ly
 w
ith
dr
aw
n
, 
an
d 
ch
ild
re
n 
w
ith
 N
D
-P
A
E 
ar
e 
m
or
e 
lik
el
y 
to
 b
e 
so
ci
al
ly
 d
isi
nh
ib
ite
d.
Pediatrics. Author manuscript; available in PMC 2017 October 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Hagan et al. Page 22
N
eu
ro
co
gn
iti
v
e
Be
ha
v
io
ra
l R
eg
ul
at
io
n
A
da
pt
iv
e 
Fu
nc
tio
ni
ng
K
ey
 D
iff
er
en
tia
l F
ro
m
 N
D
-P
A
E
•
In
 A
SD
, t
he
re
 is
 si
gn
ifi
ca
nt
 la
ck
 o
f 
so
ci
al
 a
nd
 e
m
ot
io
na
l r
ec
ip
ro
ci
ty
,
 
w
he
re
as
 in
 N
D
-P
A
E,
 th
e 
pr
ob
le
m
 is
 
so
ci
al
ly
 in
ap
pr
op
ria
te
 b
eh
av
io
r t
ha
t 
re
la
te
s t
o 
th
ei
r l
ac
k 
of
 c
au
se
-a
nd
-
ef
fe
ct
 re
as
on
in
g,
 sl
ow
 a
n
d 
in
ef
fe
ct
iv
e 
pr
oc
es
sin
g 
of
 w
ha
t p
eo
pl
e 
sa
y 
du
rin
g 
co
nv
er
sa
tio
n,
 a
nd
 la
ck
 o
f v
isu
al
–
sp
at
ia
l s
ki
lls
 th
at
 g
ov
er
n
 th
ei
r a
bi
lit
y 
to
 p
ut
 th
ei
r b
od
y 
at
 a
n 
ap
pr
op
ria
te
 
di
sta
nc
e 
fro
m
 a
no
th
er
.
•
Ch
ild
re
n 
w
ith
 A
SD
 g
en
er
al
ly
 h
av
e 
st
er
eo
ty
pi
es
 th
at
 a
re
 o
dd
 o
r v
er
y 
re
pe
tit
iv
e,
 w
hi
ch
 a
re
 n
ot
 a
s c
om
m
on
 
o
r 
m
ay
 n
ot
 b
e 
se
en
 a
t a
ll 
in
 so
m
e 
ch
ild
re
n 
w
ith
 N
D
 P
A
E.
Ea
rly
 tr
au
m
a 
ex
po
su
re
 o
r P
TS
D
In
te
lle
ct
ua
l s
ki
lls
 w
o
u
ld
 
ty
pi
ca
lly
 b
e 
w
ith
in
 n
or
m
al
 
lim
its
. F
o
r 
m
an
y,
 
th
er
e 
m
ay
 
be
 d
ef
ic
its
 a
ss
oc
ia
te
d 
w
ith
 
en
v
iro
nm
en
ta
l d
ep
riv
at
io
n,
 
bu
t w
he
n 
re
m
ov
ed
 fr
om
 th
e 
ad
ve
rs
e 
en
v
iro
nm
en
t, 
yo
un
g 
ch
ild
re
n 
of
te
n 
de
m
on
str
at
e 
dr
am
at
ic
 g
ai
ns
 in
 
de
v
el
op
m
en
ta
l f
un
ct
io
ni
ng
. 
O
ld
er
 c
hi
ld
re
n 
m
ay
 h
av
e 
m
o
re
 p
er
sis
te
nt
 c
og
ni
tiv
e 
de
fic
its
, p
ar
tic
ul
ar
ly
 in
 th
e 
ar
ea
 o
f m
em
or
y 
fu
nc
tio
ni
ng
. 
Th
e 
le
ng
th
 o
f e
x
po
su
re
 to
 
tr
au
m
a 
an
d 
en
v
iro
nm
en
ta
l 
de
pr
iv
at
io
n 
ty
pi
ca
lly
 re
la
te
s 
to
 th
e 
ex
te
nt
 o
f i
m
pa
irm
en
t.
Ch
ild
re
n 
w
ith
 P
TS
D
 o
fte
n 
ha
v
e 
ar
o
u
sa
l 
dy
sf
un
ct
io
n.
 T
he
y 
m
ay
 h
av
e 
sle
ep
 
pr
ob
le
m
s, 
be
 a
nx
io
us
, a
nd
 e
as
ily
 st
ar
tle
. 
Th
ey
 o
fte
n 
ha
v
e 
di
ffi
cu
lty
 fo
cu
sin
g 
on
 
ta
sk
s a
nd
 su
sta
in
in
g 
m
en
ta
l e
ffo
rt.
 O
fte
n 
th
es
e 
de
fic
its
 a
re
 th
e 
re
su
lt 
of
 a
nx
ie
ty
 o
r 
in
tru
siv
e 
th
ou
gh
ts.
A
da
pt
iv
e 
sk
ill
s a
re
 o
fte
n 
be
lo
w
 th
ei
r 
co
gn
iti
v
e 
fu
nc
tio
ni
ng
 sk
ill
s. 
So
m
e 
m
ay
 
ha
v
e 
de
fic
its
 a
ss
oc
ia
te
d 
w
ith
 c
ue
s 
as
so
ci
at
ed
 w
ith
 th
e 
tra
um
at
ic
 ev
en
t.
Fo
r 
m
an
y,
 
th
es
e 
de
fic
its
 m
ay
 b
e 
as
so
ci
at
ed
 w
ith
 e
nv
iro
nm
en
ta
l 
de
pr
iv
at
io
n,
 b
u
t w
he
n 
re
m
ov
ed
 fr
om
 th
e 
ad
ve
rs
e 
en
v
iro
nm
en
t a
nd
 p
la
ce
d 
in
 a
 
po
sit
iv
e,
 n
u
rt
ur
in
g 
en
v
iro
nm
en
t, 
yo
un
g 
ch
ild
re
n 
of
te
n 
de
m
on
str
at
e 
dr
am
at
ic
 
ga
in
s i
n 
de
v
el
op
m
en
ta
l f
un
ct
io
ni
ng
. 
O
ld
er
 c
hi
ld
re
n 
m
ay
 h
av
e 
m
o
re
 p
er
sis
te
nt
 
ad
ap
tiv
e 
de
fic
its
. T
he
 le
ng
th
 o
f e
x
po
su
re
 
to
 tr
au
m
a 
an
d 
en
v
iro
nm
en
ta
l d
ep
riv
at
io
n 
ty
pi
ca
lly
 re
la
te
 to
 th
e 
ex
te
nt
 o
f 
im
pa
irm
en
t.
•
Yo
u
n
g 
ch
ild
re
n 
w
ith
 P
TS
D
 
de
m
on
str
at
e 
qu
ic
ke
r 
re
co
v
er
y 
of
 
fu
nc
tio
n 
in
 c
og
ni
tiv
e 
sk
ill
s i
f p
la
ce
d 
in
to
 a
 st
ab
le
, n
ur
tu
rin
g 
en
v
iro
nm
en
t.
•
Ch
ild
re
n 
w
ith
 P
TS
D
 m
ay
 h
av
e 
m
o
re
 
an
x
ie
ty
 sy
m
pt
om
s.
•
Ch
ild
re
n 
w
ith
 P
TS
D
 m
ay
 h
av
e 
di
ffi
cu
lti
es
 fo
rm
in
g 
po
sit
iv
e 
re
la
tio
ns
hi
ps
 w
ith
 c
ar
eg
iv
er
s.
•
Th
e 
ex
te
nt
 o
f t
he
 c
og
ni
tiv
e 
im
pa
irm
en
t i
s t
yp
ic
al
ly
 n
ot
 a
s g
re
at
 
bu
t m
ay
 b
e 
in
 ex
tr
em
e 
ab
u
siv
e 
ca
se
s.
B
ip
ol
ar
 d
iso
rd
er
In
te
lle
ct
ua
l s
ki
lls
 ty
pi
ca
lly
 
ar
e 
w
ith
in
 n
or
m
al
 li
m
its
.
Th
e 
di
so
rd
er
 is
 c
ha
ra
ct
er
iz
ed
 b
y 
cy
cl
ic
 
pe
rio
ds
 o
f d
ep
re
ss
io
n 
an
d 
m
an
ia
. D
ur
in
g 
ep
iso
de
s o
f d
ep
re
ss
io
n,
 th
e 
ch
ild
’s
 a
ffe
ct
 
m
ay
 b
e 
fla
t a
nd
 h
e 
or
 sh
e 
m
ay
 la
ck
 
in
te
re
st 
in
 h
is 
or
 h
er
 p
re
fe
rre
d 
ac
tiv
iti
es
. 
D
ur
in
g 
ep
iso
de
s o
f m
an
ia
, t
he
 c
hi
ld
 m
ay
 
be
 ex
tr
em
el
y 
ac
tiv
e 
an
d 
ha
v
e 
di
ffi
cu
lty
 
o
rg
an
iz
in
g 
or
 re
gu
la
tin
g 
hi
s o
r h
er
 th
ou
gh
t 
pa
tte
rn
s. 
O
fte
n 
ch
ild
re
n 
do
 n
ot
 h
av
e 
th
e 
fu
ll 
pa
tte
rn
 o
f c
yc
lin
g 
in
 th
e 
ea
rly
 st
ag
es
 
o
f t
he
 d
iso
rd
er
 a
nd
 m
ay
 o
nl
y 
be
co
m
e 
ea
sil
y 
irr
ita
te
d 
or
 h
av
e 
sig
ni
fic
an
t m
oo
d 
la
bi
lit
y.
A
da
pt
iv
e 
sk
ill
 d
ef
ic
its
 m
ay
 o
r m
ay
 n
ot
 b
e 
pr
es
en
t b
u
t o
fte
n 
ar
e 
th
e 
re
su
lt 
of
 th
e 
m
o
o
d 
di
stu
rb
an
ce
 in
te
rfe
rin
g 
w
ith
 
le
ar
ni
ng
 a
ge
-a
pp
ro
pr
ia
te
 a
da
pt
iv
e 
sk
ill
s 
o
r 
be
in
g 
ab
le
 to
 c
ar
ry
 o
ut
 th
e 
sk
ill
s.
•
Ch
ild
re
n 
w
ith
 b
ip
ol
ar
 d
iso
rd
er
 
ty
pi
ca
lly
 d
o 
no
t h
av
e 
th
e 
sa
m
e 
m
ag
ni
tu
de
 o
f c
og
ni
tiv
e 
im
pa
irm
en
t.
A
SD
, a
ut
ism
 sp
ec
tru
m
 d
iso
rd
er
.
Pediatrics. Author manuscript; available in PMC 2017 October 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Hagan et al. Page 23
TABLE 3
ND-PAE Points for the Pediatric Medical Home
Universally screen for prenatal alcohol exposure, prenatally, in the newborn period, at the time of adoption, and for new patients; the diagnosis 
should be considered throughout childhood (especially at developmental transitions).
Document the presence and, if possible, the amount of prenatal alcohol exposure in the child’s medical chart.
Perform frequent developmental screening with early referral to developmental specialist if concerns are identified.
Identify comorbid diagnoses to effectively manage ND-PAE or, if appropriate, identify as a comorbid diagnosis.
Treat ND-PAE as a chronic condition in a medical home.
Educate women about the risks of alcohol use during pregnancy and advise them to avoid alcohol consumption while pregnant or when 
conception is possible.
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